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Summary
Background: Transcatheter occlusion of infantile patent ductus arteriosus (PDA)
challenges the interventionist.
Purpose: To analyze the risk factors for adverse events from this procedure in
patients younger than 12 months.
Subjects: We retrospectively analyzed data on 32 patients younger than 12 months
in whom transcatheter coil occlusion of a PDA was attempted. Ages ranged from 1
to 11 (median, 7) months and body weight from 1.2 to 10 (6.0) kg. The minimum
ductal diameter ranged from 1.0 to 4.6 (3.3)mm and pulmonary to systemic ﬂow
ratio from 0.7 to 12.5 (2.2). Major adverse events were deﬁned as those requir-
ing surgery, while minor adverse events included transient hemolysis not needing
treatment, coil migration with successful transcatheter retrieval, and mild left pul-
monary artery (PA) stenosis. We determined whether any factors such as age, body
weight, minimum PDA diameter, angiographic type, operator, and use of a 0.052-in.
Gianturco coil related to the occurrence of adverse events.
Results: In two patients, coils could not be deployed in the appropriate posi-
tion. They underwent surgery following transcatheter retrieval of coils. Coils were
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successfully deployed in the other 30 patients, however, one patient developed
persistent hemolysis that required surgical retrieval of the coils and closure. PDA
was completely closed in the other 29 patients (clinical success rate, 91%). Thus,
there were three major adverse events, while minor adverse events occurred in
ﬁve patients. Univariate analysis did not identify any single factor that contributed
to either major, minor, or total adverse events. However, all major adverse events
occurred in patients under 6 months and less than 6 kg body weight with a minimum
duct diameter of more than 3.5mm.
Conclusion: Transcatheter coil occlusion of PDA is feasible in selected patients younger
than 1 year. A minimum diameter more than 3.5mm in patients under 6 kg may be a
risk factor for major adverse events.
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<0.05 was considered as statistically signiﬁcant.© 2008 Japanese Colleg
reserved.
ntroduction
ranscatheter occlusion of an infantile patent duc-
us arteriosus (PDA) challenges the interventionist,
articularly when the Amplatzer duct occluder
s unavailable. The need for multiple delivery
atheters and/or long sheaths, coil migration,
esidual shunts, and coil encroachment of the aorta
r pulmonary artery (PA) are all factors threatening
successful outcome [1]. Therefore, many institu-
ions choose surgery in this age group.
Our purpose in this retrospective study was to
nalyze risk factors for adverse events of tran-
catheter occlusion of PDA in infancy.
ubjects
rom September 1997 to December 2007, two of
he authors (HT and NH) attempted coil occlu-
ion of a PDA in 32 patients under 1 year of
ge. Their ages ranged from 1 to 11 (median, 7)
onths and body weight from 1.2 to 10 (6.0) kg.
DA angiographic types were 26, type A; type C
nd E 2 each; and 1 each of B and D [2]. The
inimal diameter, measured on the lateral pro-
ection of the descending aortogram, ranged from
.0 to 4.6 (3.3)mm, and the pulmonary to sys-
emic ﬂow ratio (Qp/Qs) from 0.7 to 12.5 (2.2).
wenty-two patients had pulmonary hypertension
ith a mean pulmonary arterial pressure over
0mmHg. Although patient No. 1 had severe pul-
onary hypertension complicated by right to left
hunt, a signiﬁcant decrease in pulmonary vascular
esistance responding to oxygen encouraged us to
roceed to occlude the PDA. In April 1999, during
his study period, we introduced bioptome-assisted
elivery of the 0.052-in. Gianturco coil (052 coil) for
DA >2.5—3.0mm [3]. Ten patients underwent coil
cclusion before its introduction and 22 patients
fterwards (Table 1).
O
I
bCardiology. Published by Elsevier Ireland Ltd. All rights
After explanation of the outcome of surgery and
oil occlusion, and use of MRI incompatible stainless
teel coil, written informed consent was obtained
rom parents of patients.
ethod
oil occlusion was performed using either a snare
ssisted delivery of a 0.038-in. Gianturco coil
038 coil), a detachable PDA coil (Flipper coil), a
.035-in. platinum reverse tornade detachable coil
platinum coil), or bioptome-assisted delivery of a
52 coil (all coils are from Cook, Bloomington, IN,
SA). Delivery catheters or long sheaths were intro-
uced progradely or retrogradely depending on the
perator’s preference. The diameter of the ﬁrst coil
as at least twice the minimum diameter of the
DA. Multiple coils were deployed if necessary.
Major adverse events were deﬁned as ones
equiring surgery, that is, failure to deploy and
ubsequent surgical closure of the PDA, and per-
istent hemolysis that needed surgical retrieval of
he coils and subsequent closure. Minor adverse
vents included transient hemolysis not needing
ny treatment, migration of coils with successful
ranscatheter retrieval, and mild left pulmonary
rtery stenosis with a systolic pressure gradient
5mmHg. We determined whether factors such
s age, body weight, the PDA minimum diameter,
ngiographic type, operator, and use of the 052 coil
elated to the occurrence of adverse events.
All data are expressed as range (median), while
isk factors of adverse events were analyzed by the
nivariate analysis of regression model. A p-valueutcome
n two patients (Nos. 13 and 16), coils could not
e deployed in the appropriate position. They
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Table 1 Proﬁle of the patients.
No. Gender Age (months) Weight (kg) Qp/Qs Mean PA (mmHg) Diameter Type Operator Use of 052 Final outcome Adverse events
1 F 8 5.9 0.7 54 2.3 A 1 Yes Occlusion Minor (retrieval of migrated coil)
2 M 10 8.4 1.9 21 2.6 A 1 Yes Occlusion No
3 M 10 7.4 1.9 26 2.1 A 1 No Occlusion No
4 M 10 6.1 2.4 17 3.4 A 1 Yes Occlusion No
5 F 9 7.8 2.0 22 2.5 A 1 Yes Occlusion Minor (retrieval of migrated coil)
6 F 4 5.4 1.7 59 4.1 A 1 Yes Occlusion No
7 F 6 7.4 2.3 27 3.2 A 1 Yes Occlusion No
8 F 6 6.1 1.5 17 2.8 A 1 No Occlusion No
9 F 7 5.0 nd 58 4.5 A 1 Yes Occlusion No
10 F 8 6.0 3.6 56 3.5 A 1 Yes Occlusion No
11 F 9 6.0 2.0 58 2.9 D 1 Yes Occlusion No
12 M 9 7.0 nd 24 4.5 A 1 Yes Occlusion No
13 F 6 5.7 2.7 55 4.2 A 1 No Surgery Major (coil could not be deployed)
14 F 9 5.5 1.3 17 1.6 E 1 No Occlusion No
15 F 11 8.7 2.9 35 3.4 A 1 No Occlusion No
16 F 3 4.6 4.9 53 4.6 A 1 No Surgery Major (coil could not be deployed)
17 F 0 1.2 5.9 38 3.3 B 2 No Occlusion No
18 M 1 3.7 2.9 34 4.0 C 2 No Occlusion Minor (mild LPS)
19 M 0 2.1 12.5 49 4.4 C 2 No Occlusion No
20 F 8 5.1 3.1 45 4.0 A 2 No Occlusion Minor (transient hemolysis)
21 F 8 10.0 3.7 35 3.9 A 2 No Occlusion No
22 F 7 4.8 1.4 24 2.7 A 2 No Occlusion No
23 M 5 6.4 1.8 18 2.5 A 2 No Occlusion Minor (retrieval of migrated coil)
24 M 5 8.0 1.0 10 1.0 E 2 No Occlusion No
25 F 0 2.6 6.3 52 3.9 A 2 Yes Surgery Major (persistent hemolysis)
26 F 1 3.4 3.6 36 3.5 A 2 Yes Occlusion No
27 M 10 8.0 2.3 43 4.4 A 2 Yes Occlusion No
28 F 6 5.4 1.0 15 1.3 A 2 No Occlusion No
29 F 3 3.4 1.0 12 1.0 A 2 No Occlusion No
30 F 10 8.6 1.9 11 2.5 A 2 No Occlusion No
31 F 1 4.3 2.5 13 2.0 A 2 No Occlusion No
32 F 10 8.8 1.0 11 1.0 A 2 No Occlusion No
Abbreviations: Qp/Qs, pulmonary to systemic ﬂow ratio; mean PA, mean pulmonary artery pressure; use of 052, use of 0.052-in. Gianturco coil.
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Table 2 Univariate analysis of regression model.
Major adverse events p Minor adverse events p Total adverse events p
Age 0.7 (0.5—1.1) ns 1.0 (0.7—1.3) ns 0.9 (0.7—1.1) ns
Weight 0.7 (0.3—1.2) ns 1.0 (0.6—1.5) ns 0.8 (0.5—1.2) ns
Diameter 11.4 (0.5—245.2) ns 1.0 (0.4—2.4) ns 1.8 (0.8—4.1) ns
Type 0.7 (0.1—8.7) ns 1.0 (0.1—6.8) ns 0.8 (0.2—4.4) ns
Operator 0.5 (0.0—5.7) ns 1.6 (0.2—11.3) ns 1.0 (0.2—5.0) ns
(0.1—10.0) ns 1.8 (0.2—18.7) ns
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Figure 1 Distribution of the minimum diameter of PDA
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Data expressed as odds ratio (95% CI).
nderwent surgery following transcatheter
etrieval of the coils. Coils were successfully
eployed in the other 30 patients, however, 1
atient developed persistent hemolysis associated
ith a residual shunt that required subsequent
urgical retrieval of the coils and surgical closure.
he PDA was completely closed in the other 29
atients, which gave a clinical success rate of 91%.
Coils migrated to the pulmonary artery in two
atients (Nos. 1 and 5) because of small loop size,
hile in No. 23, did to descending aorta associ-
ted with technical error. However, these coils were
etrieved percutaneously. Re-deployment of larger
oils in Nos. 1 and 5 and the same coil in No.
3 completely closed the PDA. One procedure was
omplicated by mild left pulmonary artery stenosis
ith a systolic pressure gradient less than 5mmHg,
hile another patient developed transient hemoly-
is which resolved spontaneously.
Coils, which we initially attempted to deploy,
ere 052 coil in 14 patients, Flipper coils in 15,
latinum coils in 3, however, 2 Flipper coils could
ot be released. Only Flipper coils, 052 coil, or
latinum coils were used in 14, 6, and 3 patients,
espectively. In 6 patients, 052 coil and a Flip-
er coil were combined. The other combined use
f coils were 052 coil + 038 coil, 052 coil + Flipper
oil + 0.038 coil, and Flipper coil + 0.038 coil, one
atient for each combination. Among 14 patients in
hom only Flipper coils were used, coils could not
e delivered in 2. The number of delivered coils
as 1, 2, 3, and 5, in 10, 9, 6, and 2 patients,
espectively, while of three patients 1 received
, 1 received 6, and the third received 8 coils
Table 1).
Follow-up echocardiography showed no signiﬁ-
ant residual pulmonary hypertension in patients
ho had previously complications of pulmonary
ypertension.
Univariate analysis of regression model failedo identify any single signiﬁcant factor that con-
ributed to either major, minor, or total adverse
vents (Table 2). However, all major adverse events
ccurred in patients less than 6 months and body
o
l
d
a
ind body weight in the subjects. Adverse events: open
ircles none; closed circles major; and dotted circles
inor.
eight under 6 kg with a duct minimum diameter
ver 3.5mm (Fig. 1).
iscussion
ranscatheter occlusion of a PDA is now widely
ccepted [4—7]; coils are usually used for a small
DA, while the AMPLATZER duct occluder® (AGA
edical Co., Plymouth, MN, USA) is commonly cho-
en for moderate or large PDA [8,9]. However, 052
oil are occasionally used for a moderate sized PDA
n Japan where the AMPLATZER duct occluder® has
ot yet been approved [10]. An advantage of the
52 coil is that it is less costly [11,12].
Bilkis et al. successfully deployed the
MPLATZER duct occluder® in 205 of 209 PDAs
5mm (98%), with a complete occlusion rate in
month of 97% [13]. However, even with the use
f the AMPLATZER duct occluder®, transcatheter
cclusion of an infantile PDA is occasionally chal-
enging [1,13]. Furthermore, there are scant data
eﬁning the technical limits of the procedure such
s how small the patient or how large the PDA and
ts angiographic type might affect the outcome.
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Hijazi et al. reported successful antegrade tran-
scatheter closure with multiple Gianturco coils
in most patients with a large PDA of diameter
up to 7mm [14], while this procedure can also
be performed in neonates weighing <2.3 kg and
a PDA up to 5.2mm [15]. Kumar et al. described
bioptome-assisted coil occlusion of moderate-large
PDAs in selected infants and small children and
reported on its feasibility and encouraging results,
achieved with a relatively inexpensive procedure
[12]. We achieved a clinical success rate in this
age group of 91% and all PDAs were completely
closed without hemolysis once coils were deployed
successfully. We introduced bioptome-assisted
deployment of the 052 coil in 1999 [3]; however,
there was no signiﬁcant impact on the outcome of
this age group in this study. In our previous study,
introduction of the 052 coil simpliﬁed coil occlusion
deployment for PDA ≥2.5mm, and contributed to
a better probability of successful coil occlusion
for PDA ≥4mm [10]. The small number of patients
in our present study may limit the detection of
statistical differences between coils.
Sivakumar reported the efﬁcacy of transcatheter
closure of large patent ductus arteriosus measuring
≥4mm in patients weighing ≤6 kg in 28 patients.
In their series, 2 procedures failed one due to a
kinked sheath and in the other the device was
pulled through the ductus. Four infants needed
blood transfusions [1]. Our data showed that tran-
scatheter occlusion of PDA is an effective and
relatively safe procedure in selected infants, even
without the AMPLATZER duct occluder®. However,
a minimum diameter >3.5mm PDA in patients <6 kg
may denote a risk of major adverse events.
We could not collect data on ﬂuoroscopy time
or procedure time in this study, as these proce-
dures were performed in ﬁve different centers
with different staff other than the operator. Pro-
longed ﬂuoroscopy is a further important risk in
patients of this age who are quite radiosensitive.
We must compare these results with the risk of tran-
scatheter occlusion of PDA using the AMPLATZER
duct occluder® in this age group, once it is approved
in Japan.
Current choices of PDA occlusion in Japan
are transcatheter occlusion, conventional surgery
(ligation or division), and video-assisted tho-
racoscopic surgery. Video-assisted thoracoscopic
surgery is introduced in only limited centers, while
approximately 550 patients underwent conven-
tional surgery [16], and transcatheter occlusion was
performed in 280 patients [17]. The most clear
advantage of transcatheter occlusion over surgery
is that it is less invasive. However, as the modern
surgical mortality of uncomplicated PDA in infancyH. Tomita et al.
s nearly zero in Japan except for the preterm
nfant [16], the risk of serious complications in tran-
catheter occlusion should also be close to zero.
tainless steel coil, which has been used in the
uman body for more than 30 years [18], is now
ecognized as a harmless metal to humans. How-
ver, the lifelong safety of such a metal implanted
n infancy has not been established. MRI incom-
atibility of the stainless steel could be another
rawback in use of 052 coil. Consequently, care-
ul long term follow-up should be mandatory until
olution of these issues.
In conclusion, transcatheter occlusion of a PDA
n patients younger than 1 year is feasible and
afe as long as the minimum diameter is <3.5mm
n patients weighing >6 kg. However, patients with
PDA >3.5mm who weigh <6 kg should be sent
or surgery, until the AMPLATZER duct occluder®
ecomes available in Japan.
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